(BSCW) Invesco Exchange-Traded - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46139W8588
BSCW: Target, Maturity, Corporate, Bonds, 2032
The Invesco BulletShares 2032 Corporate Bond ETF is designed to track a specific index that focuses on U.S. dollar-denominated investment-grade corporate bonds maturing in 2032. By investing at least 80% of its assets in these securities, the fund aims to provide a targeted maturity exposure to the corporate bond market.
Given its non-diversified nature, the fund is heavily reliant on the performance of the underlying index, which is constructed to measure the performance of a portfolio of corporate bonds with maturities in 2032. This targeted approach allows investors to gain exposure to a specific segment of the corporate bond market, potentially reducing interest rate risk as the bonds approach maturity.
Analyzing the funds technical data, we observe a stable trend with the last price at $20.46, slightly above its 20-day and 50-day simple moving averages (SMA20 and SMA50). The 200-day simple moving average (SMA200) is at $20.02, indicating a gradual upward trend over the longer term. The Average True Range (ATR) is $0.14, or 0.71%, suggesting relatively low volatility.
Combining technical and fundamental insights, we can forecast that the BSCW ETF is likely to continue its stable trend, driven by the underlying corporate bonds performance as they approach maturity. With an Assets Under Management (AUM) of $894.90 million, the fund has a substantial presence in the market, which could contribute to its liquidity and stability. As interest rates and credit spreads evolve, the funds targeted maturity approach may attract investors seeking to manage their fixed-income exposure.
Looking ahead, if the current trend persists and the corporate bond market remains stable, we can expect the BSCW ETF to potentially reach its 52-week high of $20.48 or slightly exceed it, driven by the gradual appreciation of the underlying bonds as they near maturity. However, any significant changes in interest rates or credit spreads could impact the funds performance, and investors should closely monitor these factors.
Additional Sources for BSCW ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BSCW ETF Overview
Market Cap in USD | 895m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2022-09-08 |
BSCW ETF Ratings
Growth Rating | 49.0 |
Fundamental | - |
Dividend Rating | 67.4 |
Rel. Strength | -6.26 |
Analysts | - |
Fair Price Momentum | 21.03 USD |
Fair Price DCF | - |
BSCW Dividends
Dividend Yield 12m | 4.63% |
Yield on Cost 5y | 5.34% |
Annual Growth 5y | 65.89% |
Payout Consistency | 100.0% |
Payout Ratio | % |
BSCW Growth Ratios
Growth Correlation 3m | 73.5% |
Growth Correlation 12m | 51.3% |
Growth Correlation 5y | 90.5% |
CAGR 5y | 5.77% |
CAGR/Max DD 5y | 0.69 |
Sharpe Ratio 12m | 1.45 |
Alpha | 3.00 |
Beta | 0.008 |
Volatility | 5.83% |
Current Volume | 156.3k |
Average Volume 20d | 131.1k |
As of June 29, 2025, the stock is trading at USD 20.53 with a total of 156,270 shares traded.
Over the past week, the price has changed by +0.79%, over one month by +1.68%, over three months by +2.85% and over the past year by +7.28%.
Partly, yes. Based on ValueRay´s Analyses, Invesco Exchange-Traded (NASDAQ:BSCW) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.95 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BSCW is around 21.03 USD . This means that BSCW is currently overvalued and has a potential downside of 2.44%.
Invesco Exchange-Traded has no consensus analysts rating.
According to our own proprietary Forecast Model, BSCW Invesco Exchange-Traded will be worth about 22.7 in June 2026. The stock is currently trading at 20.53. This means that the stock has a potential upside of +10.67%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 22.7 | 10.7% |